
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.03 | 0.857142857143 | 3.5 | 3.7413 | 3.3 | 121397 | 3.46884223 | CS |
4 | -1.85 | -34.3866171004 | 5.38 | 5.81 | 3.3 | 300058 | 3.9031138 | CS |
12 | 0.0888 | 2.5804951761 | 3.4412 | 14.28 | 2.35 | 5677775 | 7.15913275 | CS |
26 | -5.57 | -61.2087912088 | 9.1 | 14.28 | 2.35 | 3739987 | 6.58511566 | CS |
52 | -10.33 | -74.531024531 | 13.86 | 15.5386 | 2.35 | 1922362 | 6.82598364 | CS |
156 | -37.4396 | -91.3838553464 | 40.9696 | 46.48 | 2.35 | 648454 | 7.17529583 | CS |
260 | -205.91 | -98.314553094 | 209.44 | 273.84 | 2.35 | 690421 | 69.03773839 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions